Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-liver cancer therapeutic targets and safety of usenamine A in experimental liver cancer. | J Pharm Pharmacol | 2025 | 39360781 | PubTator, text mining | PubMed |
| Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer. | Indian J Med Res | 2024 | 39513205 | PubTator, text mining | PubMed |
| E2F3-dependent activation of FAM111B restricts mouse cytomegalovirus replication in primate cells. | J Virol | 2024 | 39494906 | PubTator, text mining | PubMed |
| Study of the Role of E2F1 and TMEM132A in Prostate Cancer Development. | Front Biosci (Landmark Ed) | 2024 | 39473405 | PubTator, text mining | PubMed |
| Regorafenib promotes antitumor progression in melanoma by reducing RRM2. | iScience | 2024 | 39435141 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers in neuroblastoma using WGCNA and multi-omics analysis. | Discov Oncol | 2024 | 39302522 | PubTator, text mining | PubMed |
| Paired Transcriptomic Analyses of Atheromatous and Control Vessels Reveal Novel Autophagy and Immunoregulatory Genes in Peripheral Artery Disease. | Cells | 2024 | 39120300 | PubTator, text mining | PubMed |
| The role of palbociclib on the alterations in CDKN2, CCNE1, E2F3, MDM2 expressions as target genes of miR-141. | PLoS One | 2024 | 39116089 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis. | Biomed Res Int | 2024 | 39045407 | PubTator, text mining | PubMed |
| Insights into the role of non-coding RNAs in the development of insecticide resistance in insects. | Front Genet | 2024 | 39036703 | PubTator, text mining | PubMed |
| Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. | Curr Oncol | 2024 | 38920737 | PubTator, text mining | PubMed |
| MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function via Targeting HIF-1α and E2F3. | Curr Vasc Pharmacol | 2024 | 38910413 | PubTator, text mining | PubMed |
| Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. | Biosci Rep | 2024 | 38864530 | PubTator, text mining | PubMed |
| miR-449a: A Promising Biomarker and Therapeutic Target in Cancer and Other Diseases. | Cell Biochem Biophys | 2024 | 38809350 | PubTator, text mining | PubMed |
| PA28γ coordinates the cross-talk between cancer-associated fibroblasts and tumor cells to promote OSCC progression via HDAC1/E2F3/IGF2 signaling. | Cancer Lett | 2024 | 38768680 | PubTator, text mining | PubMed |
| Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells. | Biomol Concepts | 2024 | 38525814 | PubTator, text mining | PubMed |
| Circ_0001495 influences the development of endometriosis through the miRNA-34c-5p/E2F3 axis. | Reprod Biol | 2024 | 38458026 | PubTator, text mining | PubMed |
| FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. | Mol Carcinog | 2024 | 38380957 | PubTator, text mining | PubMed |
| Targeting circulating labile heme as a defense strategy against malaria. | Life Sci Alliance | 2024 | 38307624 | PubTator, text mining | PubMed |
| Exosomal microRNAs in regulation of tumor cells resistance to apoptosis. | Biochem Biophys Rep | 2024 | 38298209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=5